Unlock stock picks and a broker-level newsfeed that powers Wall Street.
256.00
-11.00
(-4.12%)
At close: April 4 at 3:30:00 PM GMT+9
Key Executives
Amounts are as of December 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Takashi Shibata | President, CEO & Representative Director | 116.39M | -- | 1956 |
| Tsuyoshi Honma | Executive Officer of Accounting & IT | -- | -- | -- |
| Konosuke Tanaka | Executive Officer of Personnel Affairs & Public Relations | -- | -- | -- |
| Takatoshi Osada | Senior Executive Officer of Marketing & Sales | -- | -- | -- |
| Mitsuhiro Yamashita | Executive Officer of Overseas Business | -- | -- | -- |
| Shinichi Seki | Executive Officer & GM of Infection Control Business Development Division | -- | -- | -- |
| Mr. Masaji Hashimoto | Senior Managing Director & Director | -- | -- | 1967 |
| Keizo Nakada | Executive Officer | -- | -- | -- |
Taiko Pharmaceutical Co.,Ltd.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines in Japan and internationally. The company provides OTC medicines for the treatment of loose stools, diarrhea, vomiting, food and water poisoning symptoms, and toothache; and quasi-drugs for regulation of intestinal movements, relieves stomach distention, loose stools, and constipation. It manufactures and sells infection control products. Taiko Pharmaceutical Co.,Ltd. exports its products. The company was incorporated in 1946 and is headquartered in Osaka, Japan.
Corporate Governance
Taiko Pharmaceutical Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 8, 2025 at 6:30 AM UTC - May 12, 2025 at 6:30 AM UTC
Taiko Pharmaceutical Co.,Ltd. Earnings Date
Recent Events
December 29, 2021 at 12:00 AM UTC
Ex-Dividend Date